Angiogenesis Inhibitor Pazopanib HCl Raw Pazopanib Powder

• Customization: Available
• CAS No.: 635702-64-6
• Formula: C21h23n7o2s.Clh
• Model NO.: QS-Pazopanib HCl
• EINECS: 619-728-0
• Packaging Material: Metal
• Storage Method: Normal
• Shelf Life: >12 Months
• Product Name: Pazopanib HCl
• Name: Pazopanib HCl Powder
• Appearance: White Powder
• Grade: Pharmaceutical
• Colour: White
• Assay: 99%
• Application: Pharmaceutical
• Specific: 99%
• Test Method: HPLC
• Mf: C21h23n7o2s.Clh
• MW: 473.972
• Density: 1.2-1.4G/Cm3
• Melting Point: >290°c
• Boiling Point: 700°c
• pH: 4.1
• Transport Package: Negotiable
• Specification: Negotiable
• Trademark: QS
• Origin: Shaanxi Xi′an
• Production Capacity: 600kg/Month

Product Description

Angiogenesis Inhibitor Pazopanib HCl Raw Pazopanib Powder

Product Description

Product Details

Product Name	Pazopanib HCL
CASNO.	635702-64-6
Appearance	White Powder
MF	C21H23N7O2S.ClH
MW	473.972

Pazopanib HCl is a multi-target tyrosine kinase inhibitor primarily used for the treatment of various cancers, including renal cell carcinoma, ovarian cancer, non-small cell lung cancer (NSCLC), and soft tissue sarcoma (STS)

Application&Function

Renal cell carcinoma: Pazopanib HCl is used as first-line treatment for advanced renal cell carcinoma patients, as well as for the treatment of advanced renal cell carcinoma patients who have received cytokine therapy. It can significantly prolong the survival of patients and alleviate disease-related symptoms.
Ovarian cancer: Pazopanib HCl exhibits certain activity in the treatment of platinum resistant or platinum refractory epithelial ovarian cancer, which can inhibit the growth and spread of tumor cells and improve the survival prognosis of patients

Specification